INTRODUCTION
Tautomycetin is a polyketide natural product recognized as an inhibitor of serine/threonine phosphatases type I. 1 In spite of this important activity, there is no total synthesis described in the literature. 2 For this reason, we have proposed a project aiming to the total synthesis of tautomycetin. We wish to describe here our approach to fragments C7'-17 and C1-C12 of tautomycetin. Alkyne 2 was added to MeCuLiCN followed by addition of penten-3-enoyl chloride to afford 3. Compound 3 was converted into 4 through asymmetric reduction, protection of the hydroxyl group and oxidative cleavage of the olefin moiety. Alcohol 6 was synthesized from Roche ester through protection of its primary hydroxyl group, reduction of the ester group, oxidation and Me 2 LiCu addition to the intermediate aldehyde. Compounds 4 and 6 were coupled by Yamaguchi esterification to afford the C7'-17 fragment 7 (Scheme 1). S-()-citronellal was converted into terminal olefin 8, by Wittig reaction. This olefin was the substrate for the ZACA reaction which lead to asymmetric methyl addition with concomitant primary hydroxyl formation. 3 Finally, modified Appel reaction changing the hydroxyl for iodine provided iodide 9. The ester 12 was prepared by a cross coupling reaction between compounds 10 and 11. The aldehyde 13 was synthesized from ester 12, through reduction followed by oxidation. Compounds 9 and 13 were coupled by halogen-lithium exchange of 9, followed by addition of 13 providing 14 in 57% yield (scheme 2).
CONCLUSION

